Rankings
▼
Calendar
IDXX Q2 2022 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena
IDXX
IDEXX Laboratories, Inc.
$48B
Q2 2022 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$861M
+4.2% YoY
Gross Profit
$514M
59.7% margin
Operating Income
$179M
20.8% margin
Net Income
$132M
15.3% margin
EPS (Diluted)
$1.56
QoQ Revenue Growth
+2.9%
Cash Flow
Operating Cash Flow
$66M
Free Cash Flow
$36M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$2.6B
Total Liabilities
$2.2B
Stockholders' Equity
$457M
Cash & Equivalents
$114M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$861M
$826M
+4.2%
Gross Profit
$514M
$489M
+5.1%
Operating Income
$179M
$259M
-30.9%
Net Income
$132M
$203M
-34.9%
Revenue Segments
Up Front Customer Loyalty Programs And Volume Commitment Programs
$3.0B
98%
Reagent Rental Programs
$36M
1%
Extended Warranties And Post Contract Support
$13M
0%
Instrument Rebate Programs
$3M
0%
Geographic Segments
UNITED STATES
$560M
65%
EMEA
$162M
19%
Asia Pacific
$80M
9%
CANADA
$40M
5%
Latin America
$19M
2%
← FY 2022
All Quarters
Q3 2022 →